nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—MAOA—Parkinson's disease	0.284	0.368	CbGaD
Sumatriptan—HTR1A—Parkinson's disease	0.214	0.278	CbGaD
Sumatriptan—DRD2—Parkinson's disease	0.182	0.236	CbGaD
Sumatriptan—ABCB1—Parkinson's disease	0.0918	0.119	CbGaD
Sumatriptan—HTR3A—enteric nervous system—Parkinson's disease	0.0121	0.139	CbGeAlD
Sumatriptan—HTR3A—myenteric nerve plexus—Parkinson's disease	0.0092	0.106	CbGeAlD
Sumatriptan—MAOA—locus ceruleus—Parkinson's disease	0.00496	0.0569	CbGeAlD
Sumatriptan—HTR1B—telencephalic ventricle—Parkinson's disease	0.00319	0.0366	CbGeAlD
Sumatriptan—HTR1D—telencephalic ventricle—Parkinson's disease	0.00309	0.0354	CbGeAlD
Sumatriptan—HTR1A—telencephalic ventricle—Parkinson's disease	0.00257	0.0295	CbGeAlD
Sumatriptan—HTR3A—nerve—Parkinson's disease	0.0024	0.0275	CbGeAlD
Sumatriptan—DRD2—telencephalic ventricle—Parkinson's disease	0.00232	0.0267	CbGeAlD
Sumatriptan—HTR1F—forebrain—Parkinson's disease	0.00203	0.0233	CbGeAlD
Sumatriptan—MAOA—nerve—Parkinson's disease	0.00148	0.017	CbGeAlD
Sumatriptan—DRD2—nerve—Parkinson's disease	0.00147	0.0168	CbGeAlD
Sumatriptan—Melatonin—NQO2—Parkinson's disease	0.00123	0.159	CrCbGaD
Sumatriptan—HTR1A—hindbrain—Parkinson's disease	0.00121	0.0139	CbGeAlD
Sumatriptan—HTR1F—head—Parkinson's disease	0.00116	0.0134	CbGeAlD
Sumatriptan—MAOA—hindbrain—Parkinson's disease	0.00111	0.0127	CbGeAlD
Sumatriptan—HTR1F—nervous system—Parkinson's disease	0.0011	0.0127	CbGeAlD
Sumatriptan—DRD2—hindbrain—Parkinson's disease	0.0011	0.0126	CbGeAlD
Sumatriptan—HTR1F—central nervous system—Parkinson's disease	0.00106	0.0122	CbGeAlD
Sumatriptan—HTR3A—brainstem—Parkinson's disease	0.00103	0.0118	CbGeAlD
Sumatriptan—HTR3A—forebrain—Parkinson's disease	0.000992	0.0114	CbGeAlD
Sumatriptan—Naratriptan—MAOA—Parkinson's disease	0.000954	0.123	CrCbGaD
Sumatriptan—HTR1B—brainstem—Parkinson's disease	0.000863	0.0099	CbGeAlD
Sumatriptan—HTR1F—brain—Parkinson's disease	0.000843	0.00968	CbGeAlD
Sumatriptan—HTR1D—brainstem—Parkinson's disease	0.000835	0.00958	CbGeAlD
Sumatriptan—HTR1B—forebrain—Parkinson's disease	0.000833	0.00955	CbGeAlD
Sumatriptan—HTR1D—forebrain—Parkinson's disease	0.000806	0.00925	CbGeAlD
Sumatriptan—Rizatriptan—MAOA—Parkinson's disease	0.000791	0.102	CrCbGaD
Sumatriptan—SLCO1A2—forebrain—Parkinson's disease	0.000783	0.00899	CbGeAlD
Sumatriptan—Zolmitriptan—MAOA—Parkinson's disease	0.000723	0.093	CrCbGaD
Sumatriptan—Naratriptan—HTR1A—Parkinson's disease	0.000721	0.0927	CrCbGaD
Sumatriptan—HTR1B—cardiovascular system—Parkinson's disease	0.000704	0.00808	CbGeAlD
Sumatriptan—HTR1A—brainstem—Parkinson's disease	0.000696	0.00799	CbGeAlD
Sumatriptan—MAOA—embryo—Parkinson's disease	0.000694	0.00796	CbGeAlD
Sumatriptan—HTR1D—cardiovascular system—Parkinson's disease	0.000682	0.00782	CbGeAlD
Sumatriptan—HTR1A—forebrain—Parkinson's disease	0.000672	0.00771	CbGeAlD
Sumatriptan—MAOA—brainstem—Parkinson's disease	0.000636	0.0073	CbGeAlD
Sumatriptan—DRD2—brainstem—Parkinson's disease	0.000629	0.00722	CbGeAlD
Sumatriptan—MAOA—forebrain—Parkinson's disease	0.000614	0.00704	CbGeAlD
Sumatriptan—DRD2—forebrain—Parkinson's disease	0.000607	0.00697	CbGeAlD
Sumatriptan—Rizatriptan—HTR1A—Parkinson's disease	0.000597	0.0768	CrCbGaD
Sumatriptan—HTR3A—head—Parkinson's disease	0.000568	0.00652	CbGeAlD
Sumatriptan—HTR1A—cardiovascular system—Parkinson's disease	0.000568	0.00652	CbGeAlD
Sumatriptan—SLCO1A2—medulla oblongata—Parkinson's disease	0.000566	0.00649	CbGeAlD
Sumatriptan—HTR1B—midbrain—Parkinson's disease	0.00055	0.00631	CbGeAlD
Sumatriptan—Almotriptan—MAOA—Parkinson's disease	0.000548	0.0705	CrCbGaD
Sumatriptan—Zolmitriptan—HTR1A—Parkinson's disease	0.000546	0.0703	CrCbGaD
Sumatriptan—HTR3A—nervous system—Parkinson's disease	0.000539	0.00618	CbGeAlD
Sumatriptan—HTR1B—spinal cord—Parkinson's disease	0.000536	0.00616	CbGeAlD
Sumatriptan—HTR1D—midbrain—Parkinson's disease	0.000532	0.00611	CbGeAlD
Sumatriptan—MAOA—cardiovascular system—Parkinson's disease	0.000519	0.00596	CbGeAlD
Sumatriptan—HTR3A—central nervous system—Parkinson's disease	0.000519	0.00595	CbGeAlD
Sumatriptan—SLCO1A2—midbrain—Parkinson's disease	0.000517	0.00594	CbGeAlD
Sumatriptan—SLCO1A2—spinal cord—Parkinson's disease	0.000505	0.00579	CbGeAlD
Sumatriptan—HTR1B—head—Parkinson's disease	0.000477	0.00547	CbGeAlD
Sumatriptan—HTR1D—head—Parkinson's disease	0.000462	0.0053	CbGeAlD
Sumatriptan—HTR1B—nervous system—Parkinson's disease	0.000452	0.00519	CbGeAlD
Sumatriptan—SLCO1A2—head—Parkinson's disease	0.000448	0.00515	CbGeAlD
Sumatriptan—HTR1A—midbrain—Parkinson's disease	0.000444	0.00509	CbGeAlD
Sumatriptan—MAOA—medulla oblongata—Parkinson's disease	0.000443	0.00509	CbGeAlD
Sumatriptan—HTR1D—nervous system—Parkinson's disease	0.000438	0.00502	CbGeAlD
Sumatriptan—HTR1B—central nervous system—Parkinson's disease	0.000435	0.00499	CbGeAlD
Sumatriptan—HTR1A—spinal cord—Parkinson's disease	0.000433	0.00497	CbGeAlD
Sumatriptan—SLCO1A2—nervous system—Parkinson's disease	0.000425	0.00488	CbGeAlD
Sumatriptan—HTR1D—central nervous system—Parkinson's disease	0.000421	0.00483	CbGeAlD
Sumatriptan—Eletriptan—HTR7—Parkinson's disease	0.000421	0.0541	CrCbGaD
Sumatriptan—HTR3A—brain—Parkinson's disease	0.000412	0.00473	CbGeAlD
Sumatriptan—SLCO1A2—central nervous system—Parkinson's disease	0.000409	0.0047	CbGeAlD
Sumatriptan—MAOA—midbrain—Parkinson's disease	0.000405	0.00465	CbGeAlD
Sumatriptan—DRD2—midbrain—Parkinson's disease	0.000401	0.0046	CbGeAlD
Sumatriptan—SLCO1A2—cerebellum—Parkinson's disease	0.0004	0.00459	CbGeAlD
Sumatriptan—MAOA—spinal cord—Parkinson's disease	0.000395	0.00454	CbGeAlD
Sumatriptan—HTR1A—head—Parkinson's disease	0.000385	0.00441	CbGeAlD
Sumatriptan—ABCG2—medulla oblongata—Parkinson's disease	0.000384	0.00441	CbGeAlD
Sumatriptan—HTR1A—nervous system—Parkinson's disease	0.000365	0.00419	CbGeAlD
Sumatriptan—MAOA—head—Parkinson's disease	0.000351	0.00403	CbGeAlD
Sumatriptan—ABCG2—midbrain—Parkinson's disease	0.000351	0.00403	CbGeAlD
Sumatriptan—HTR1A—central nervous system—Parkinson's disease	0.000351	0.00403	CbGeAlD
Sumatriptan—DRD2—head—Parkinson's disease	0.000348	0.00399	CbGeAlD
Sumatriptan—HTR1B—brain—Parkinson's disease	0.000345	0.00396	CbGeAlD
Sumatriptan—HTR1A—cerebellum—Parkinson's disease	0.000343	0.00394	CbGeAlD
Sumatriptan—ABCG2—spinal cord—Parkinson's disease	0.000343	0.00393	CbGeAlD
Sumatriptan—Almotriptan—CYP2E1—Parkinson's disease	0.000338	0.0435	CrCbGaD
Sumatriptan—HTR1D—brain—Parkinson's disease	0.000334	0.00384	CbGeAlD
Sumatriptan—MAOA—nervous system—Parkinson's disease	0.000333	0.00382	CbGeAlD
Sumatriptan—DRD2—nervous system—Parkinson's disease	0.00033	0.00378	CbGeAlD
Sumatriptan—SLCO1A2—brain—Parkinson's disease	0.000325	0.00373	CbGeAlD
Sumatriptan—Eletriptan—HTR1A—Parkinson's disease	0.000323	0.0415	CrCbGaD
Sumatriptan—MAOA—central nervous system—Parkinson's disease	0.000321	0.00368	CbGeAlD
Sumatriptan—DRD2—central nervous system—Parkinson's disease	0.000317	0.00364	CbGeAlD
Sumatriptan—MAOA—cerebellum—Parkinson's disease	0.000314	0.0036	CbGeAlD
Sumatriptan—DRD2—cerebellum—Parkinson's disease	0.00031	0.00356	CbGeAlD
Sumatriptan—ABCB1—embryo—Parkinson's disease	0.000297	0.0034	CbGeAlD
Sumatriptan—HTR1A—brain—Parkinson's disease	0.000279	0.0032	CbGeAlD
Sumatriptan—ABCG2—cerebellum—Parkinson's disease	0.000272	0.00312	CbGeAlD
Sumatriptan—ABCB1—forebrain—Parkinson's disease	0.000262	0.00301	CbGeAlD
Sumatriptan—MAOA—brain—Parkinson's disease	0.000255	0.00292	CbGeAlD
Sumatriptan—DRD2—brain—Parkinson's disease	0.000252	0.00289	CbGeAlD
Sumatriptan—Almotriptan—CYP2D6—Parkinson's disease	0.000248	0.0319	CrCbGaD
Sumatriptan—ABCB1—cardiovascular system—Parkinson's disease	0.000222	0.00255	CbGeAlD
Sumatriptan—ABCG2—brain—Parkinson's disease	0.000221	0.00253	CbGeAlD
Sumatriptan—Eletriptan—CYP2D6—Parkinson's disease	0.000194	0.0249	CrCbGaD
Sumatriptan—ABCB1—medulla oblongata—Parkinson's disease	0.00019	0.00218	CbGeAlD
Sumatriptan—ABCB1—midbrain—Parkinson's disease	0.000173	0.00199	CbGeAlD
Sumatriptan—ABCB1—spinal cord—Parkinson's disease	0.000169	0.00194	CbGeAlD
Sumatriptan—ABCB1—head—Parkinson's disease	0.00015	0.00172	CbGeAlD
Sumatriptan—ABCB1—nervous system—Parkinson's disease	0.000142	0.00163	CbGeAlD
Sumatriptan—Eletriptan—ABCB1—Parkinson's disease	0.000138	0.0178	CrCbGaD
Sumatriptan—ABCB1—central nervous system—Parkinson's disease	0.000137	0.00157	CbGeAlD
Sumatriptan—ABCB1—cerebellum—Parkinson's disease	0.000134	0.00154	CbGeAlD
Sumatriptan—ABCB1—brain—Parkinson's disease	0.000109	0.00125	CbGeAlD
Sumatriptan—SLCO1B1—Metabolism—PLA2G6—Parkinson's disease	2.43e-05	0.000182	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TALDO1—Parkinson's disease	2.42e-05	0.000181	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—OMD—Parkinson's disease	2.42e-05	0.000181	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—EDN1—Parkinson's disease	2.41e-05	0.000181	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—MAOB—Parkinson's disease	2.41e-05	0.00018	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GRM4—Parkinson's disease	2.4e-05	0.000179	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	2.39e-05	0.000179	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—TAC1—Parkinson's disease	2.38e-05	0.000178	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—EDN1—Parkinson's disease	2.36e-05	0.000177	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GRK5—Parkinson's disease	2.35e-05	0.000176	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—HTR1A—Parkinson's disease	2.33e-05	0.000175	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—DRD1—Parkinson's disease	2.33e-05	0.000174	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.32e-05	0.000174	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—TAC1—Parkinson's disease	2.3e-05	0.000172	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NDUFB11—Parkinson's disease	2.29e-05	0.000171	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.29e-05	0.000171	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PENK—Parkinson's disease	2.27e-05	0.00017	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAG—Parkinson's disease	2.27e-05	0.00017	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—FGF20—Parkinson's disease	2.27e-05	0.00017	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—DRD3—Parkinson's disease	2.26e-05	0.000169	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—DRD1—Parkinson's disease	2.25e-05	0.000169	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PLA2G6—Parkinson's disease	2.25e-05	0.000168	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—HTR7—Parkinson's disease	2.25e-05	0.000168	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—DRD2—Parkinson's disease	2.25e-05	0.000168	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—MAOB—Parkinson's disease	2.23e-05	0.000167	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FGF20—Parkinson's disease	2.23e-05	0.000166	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.22e-05	0.000166	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ADORA2A—Parkinson's disease	2.2e-05	0.000165	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—EDN1—Parkinson's disease	2.19e-05	0.000164	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GCH1—Parkinson's disease	2.19e-05	0.000164	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—DRD3—Parkinson's disease	2.18e-05	0.000163	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ADORA2A—Parkinson's disease	2.16e-05	0.000161	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—EDN1—Parkinson's disease	2.15e-05	0.000161	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HTR1A—Parkinson's disease	2.12e-05	0.000159	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IGF2—Parkinson's disease	2.12e-05	0.000158	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—HTR2A—Parkinson's disease	2.11e-05	0.000158	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—ADRBK1—Parkinson's disease	2.11e-05	0.000158	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GRM4—Parkinson's disease	2.11e-05	0.000157	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CYP2D6—Parkinson's disease	2.09e-05	0.000156	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—TAC1—Parkinson's disease	2.09e-05	0.000156	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PDYN—Parkinson's disease	2.08e-05	0.000155	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—HTR2A—Parkinson's disease	2.07e-05	0.000155	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CTGF—Parkinson's disease	2.05e-05	0.000154	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IGF1R—Parkinson's disease	2.05e-05	0.000153	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—DRD1—Parkinson's disease	2.05e-05	0.000153	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—DRD2—Parkinson's disease	2.04e-05	0.000153	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HTR7—Parkinson's disease	2.04e-05	0.000153	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.04e-05	0.000152	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—INSR—Parkinson's disease	2.03e-05	0.000152	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EDN1—Parkinson's disease	2.03e-05	0.000151	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PENK—Parkinson's disease	2e-05	0.000149	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAG—Parkinson's disease	2e-05	0.000149	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—INSR—Parkinson's disease	1.99e-05	0.000149	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—DRD3—Parkinson's disease	1.98e-05	0.000148	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	1.97e-05	0.000148	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GFAP—Parkinson's disease	1.96e-05	0.000146	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—DBH—Parkinson's disease	1.95e-05	0.000146	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—FBP1—Parkinson's disease	1.95e-05	0.000146	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GBA—Parkinson's disease	1.95e-05	0.000146	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CYP2D6—Parkinson's disease	1.94e-05	0.000145	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GRM5—Parkinson's disease	1.93e-05	0.000145	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—FGB—Parkinson's disease	1.92e-05	0.000144	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—HTR2A—Parkinson's disease	1.92e-05	0.000143	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CYP2E1—Parkinson's disease	1.91e-05	0.000143	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HTR1A—Parkinson's disease	1.91e-05	0.000143	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CTGF—Parkinson's disease	1.9e-05	0.000142	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—NQO1—Parkinson's disease	1.89e-05	0.000141	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TAC1—Parkinson's disease	1.88e-05	0.000141	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FGB—Parkinson's disease	1.88e-05	0.000141	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—HTR2A—Parkinson's disease	1.88e-05	0.00014	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HTR1A—Parkinson's disease	1.87e-05	0.00014	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—TH—Parkinson's disease	1.86e-05	0.000139	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—NGF—Parkinson's disease	1.86e-05	0.000139	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	1.85e-05	0.000138	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—DRD1—Parkinson's disease	1.85e-05	0.000138	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TAC1—Parkinson's disease	1.84e-05	0.000138	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PDYN—Parkinson's disease	1.83e-05	0.000137	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—DRD1—Parkinson's disease	1.81e-05	0.000135	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—EDN1—Parkinson's disease	1.8e-05	0.000135	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	1.79e-05	0.000134	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CYCS—Parkinson's disease	1.79e-05	0.000134	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—DRD3—Parkinson's disease	1.79e-05	0.000134	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CYP2D6—Parkinson's disease	1.79e-05	0.000134	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CYP2E1—Parkinson's disease	1.77e-05	0.000133	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HTR2A—Parkinson's disease	1.77e-05	0.000132	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CTGF—Parkinson's disease	1.76e-05	0.000131	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—NQO1—Parkinson's disease	1.75e-05	0.000131	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—DRD3—Parkinson's disease	1.75e-05	0.000131	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	1.75e-05	0.000131	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—TH—Parkinson's disease	1.73e-05	0.000129	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GFAP—Parkinson's disease	1.72e-05	0.000128	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.7e-05	0.000127	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GRM5—Parkinson's disease	1.7e-05	0.000127	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGF20—Parkinson's disease	1.7e-05	0.000127	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ADRBK1—Parkinson's disease	1.67e-05	0.000125	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CYCS—Parkinson's disease	1.66e-05	0.000124	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CYP2D6—Parkinson's disease	1.66e-05	0.000124	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—APOE—Parkinson's disease	1.65e-05	0.000123	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ADORA2A—Parkinson's disease	1.64e-05	0.000123	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.64e-05	0.000122	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CYP2E1—Parkinson's disease	1.64e-05	0.000122	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ADRBK1—Parkinson's disease	1.64e-05	0.000122	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—EDN1—Parkinson's disease	1.64e-05	0.000122	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CTGF—Parkinson's disease	1.63e-05	0.000122	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HTR7—Parkinson's disease	1.62e-05	0.000121	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—DRD2—Parkinson's disease	1.62e-05	0.000121	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—NQO1—Parkinson's disease	1.62e-05	0.000121	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	1.61e-05	0.00012	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—TH—Parkinson's disease	1.59e-05	0.000119	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	1.59e-05	0.000119	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—COMT—Parkinson's disease	1.59e-05	0.000119	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HTR7—Parkinson's disease	1.58e-05	0.000118	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—DRD2—Parkinson's disease	1.58e-05	0.000118	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	1.58e-05	0.000118	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GSTP1—Parkinson's disease	1.58e-05	0.000118	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	1.58e-05	0.000118	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—MAOA—Parkinson's disease	1.57e-05	0.000118	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—HMOX1—Parkinson's disease	1.56e-05	0.000116	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CYCS—Parkinson's disease	1.53e-05	0.000114	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—INSR—Parkinson's disease	1.52e-05	0.000113	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CYP2E1—Parkinson's disease	1.51e-05	0.000113	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—NQO1—Parkinson's disease	1.5e-05	0.000112	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ABCB1—Parkinson's disease	1.49e-05	0.000112	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGF20—Parkinson's disease	1.49e-05	0.000111	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—TH—Parkinson's disease	1.48e-05	0.00011	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—COMT—Parkinson's disease	1.47e-05	0.00011	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTP1—Parkinson's disease	1.46e-05	0.000109	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GSTM1—Parkinson's disease	1.45e-05	0.000108	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	1.44e-05	0.000108	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—HMOX1—Parkinson's disease	1.44e-05	0.000108	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	1.44e-05	0.000107	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGB—Parkinson's disease	1.43e-05	0.000107	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—DDC—Parkinson's disease	1.43e-05	0.000107	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HTR2A—Parkinson's disease	1.43e-05	0.000107	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.42e-05	0.000106	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CYCS—Parkinson's disease	1.42e-05	0.000106	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—INS—Parkinson's disease	1.41e-05	0.000105	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TAC1—Parkinson's disease	1.4e-05	0.000105	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GPX1—Parkinson's disease	1.39e-05	0.000104	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ABCB1—Parkinson's disease	1.38e-05	0.000103	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	1.38e-05	0.000103	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DRD1—Parkinson's disease	1.38e-05	0.000103	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF2—Parkinson's disease	1.36e-05	0.000101	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—COMT—Parkinson's disease	1.36e-05	0.000101	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTA4—Parkinson's disease	1.35e-05	0.000101	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTP1—Parkinson's disease	1.35e-05	0.000101	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—MAOA—Parkinson's disease	1.35e-05	0.000101	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTM1—Parkinson's disease	1.34e-05	0.0001	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DRD3—Parkinson's disease	1.33e-05	9.98e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—INSR—Parkinson's disease	1.33e-05	9.96e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—HMOX1—Parkinson's disease	1.33e-05	9.95e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF2—Parkinson's disease	1.33e-05	9.92e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF1R—Parkinson's disease	1.31e-05	9.8e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EDN1—Parkinson's disease	1.3e-05	9.68e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GPX1—Parkinson's disease	1.29e-05	9.62e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF1R—Parkinson's disease	1.28e-05	9.6e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—MTHFR—Parkinson's disease	1.28e-05	9.58e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ABCB1—Parkinson's disease	1.28e-05	9.55e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.27e-05	9.5e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EDN1—Parkinson's disease	1.27e-05	9.48e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGB—Parkinson's disease	1.26e-05	9.41e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	1.26e-05	9.39e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—COMT—Parkinson's disease	1.26e-05	9.38e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	1.25e-05	9.36e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTP1—Parkinson's disease	1.25e-05	9.34e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—MAOA—Parkinson's disease	1.25e-05	9.32e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	1.25e-05	9.32e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTM1—Parkinson's disease	1.24e-05	9.27e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TAC1—Parkinson's disease	1.23e-05	9.22e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—HMOX1—Parkinson's disease	1.23e-05	9.21e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.22e-05	9.1e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—DRD1—Parkinson's disease	1.21e-05	9.04e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	1.21e-05	9.02e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	1.21e-05	9.02e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MAOB—Parkinson's disease	1.2e-05	9.01e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—APOE—Parkinson's disease	1.19e-05	8.92e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NGF—Parkinson's disease	1.19e-05	8.9e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GPX1—Parkinson's disease	1.19e-05	8.88e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—MTHFR—Parkinson's disease	1.19e-05	8.88e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ABCB1—Parkinson's disease	1.18e-05	8.84e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—DRD3—Parkinson's disease	1.17e-05	8.76e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NGF—Parkinson's disease	1.17e-05	8.71e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTM1—Parkinson's disease	1.15e-05	8.58e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HTR2A—Parkinson's disease	1.13e-05	8.47e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HTR2A—Parkinson's disease	1.11e-05	8.29e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—APOE—Parkinson's disease	1.11e-05	8.26e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GPX1—Parkinson's disease	1.1e-05	8.22e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—MTHFR—Parkinson's disease	1.1e-05	8.19e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	1.09e-05	8.18e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HTR7—Parkinson's disease	1.06e-05	7.92e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APOE—Parkinson's disease	1.05e-05	7.88e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CASP3—Parkinson's disease	1.05e-05	7.83e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL6—Parkinson's disease	1.04e-05	7.78e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APOE—Parkinson's disease	1.03e-05	7.71e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—APOE—Parkinson's disease	1.02e-05	7.63e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—INS—Parkinson's disease	1.02e-05	7.62e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—MTHFR—Parkinson's disease	1.01e-05	7.59e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	1.01e-05	7.56e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	9.78e-06	7.31e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	9.66e-06	7.22e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MAPK8—Parkinson's disease	9.63e-06	7.2e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APOE—Parkinson's disease	9.44e-06	7.06e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—INS—Parkinson's disease	9.44e-06	7.06e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—INS—Parkinson's disease	9e-06	6.73e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP2D6—Parkinson's disease	8.95e-06	6.69e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF2—Parkinson's disease	8.88e-06	6.64e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NGF—Parkinson's disease	8.88e-06	6.64e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—INS—Parkinson's disease	8.81e-06	6.59e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CTGF—Parkinson's disease	8.79e-06	6.57e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—INS—Parkinson's disease	8.71e-06	6.52e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	8.58e-06	6.42e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EDN1—Parkinson's disease	8.48e-06	6.34e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	8.45e-06	6.32e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP2E1—Parkinson's disease	8.19e-06	6.12e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NQO1—Parkinson's disease	8.1e-06	6.05e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—INS—Parkinson's disease	8.07e-06	6.03e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TH—Parkinson's disease	7.98e-06	5.97e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOE—Parkinson's disease	7.86e-06	5.87e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NGF—Parkinson's disease	7.79e-06	5.83e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYCS—Parkinson's disease	7.66e-06	5.73e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	7.42e-06	5.55e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOE—Parkinson's disease	6.9e-06	5.16e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—COMT—Parkinson's disease	6.79e-06	5.07e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTP1—Parkinson's disease	6.75e-06	5.05e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MAOA—Parkinson's disease	6.74e-06	5.04e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—INS—Parkinson's disease	6.71e-06	5.02e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	6.7e-06	5.01e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HMOX1—Parkinson's disease	6.66e-06	4.98e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	6.66e-06	4.98e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	6.56e-06	4.9e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	6.52e-06	4.87e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTM1—Parkinson's disease	6.21e-06	4.64e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	6.16e-06	4.6e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—Parkinson's disease	6.15e-06	4.6e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	6.03e-06	4.51e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GPX1—Parkinson's disease	5.94e-06	4.44e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—INS—Parkinson's disease	5.89e-06	4.41e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MTHFR—Parkinson's disease	5.48e-06	4.1e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOE—Parkinson's disease	5.11e-06	3.82e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	5e-06	3.74e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	4.96e-06	3.71e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	4.59e-06	3.43e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CASP3—Parkinson's disease	4.39e-06	3.28e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—INS—Parkinson's disease	4.36e-06	3.26e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—Parkinson's disease	4.36e-06	3.26e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	4.03e-06	3.01e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—Parkinson's disease	3.93e-06	2.94e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—Parkinson's disease	3.85e-06	2.88e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—Parkinson's disease	2.93e-06	2.19e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—Parkinson's disease	2.57e-06	1.93e-05	CbGpPWpGaD
